Skip to main content
. 2022 Apr 13;10:823387. doi: 10.3389/fcell.2022.823387

FIGURE 3.

FIGURE 3

Pharmacological interventions on atherosclerosis through potentially targeting to NLRP3 inflammasome. Statins, natural medication and novel medication directly or indirectly inhibit assembly and activation of NLRP3 inflammasome as well as secretion of IL-1β and IL-18, which inhibit the occurrence of atherosclerosis.